EMEA-000876-PIP01-10-M01

Key facts

Invented name
Soliris
Active substance
Eculizumab
Therapeutic area
Immunology-Rheumatology-Transplantation
Decision number
P/0290/2014
PIP number
EMEA-000876-PIP01-10-M01
Pharmaceutical form(s)
Concentrate for solution for infusion
Condition(s) / indication(s)
  • Treatment of Atypical Haemolytic Uraemic Syndrome
  • Treatment of paroxysmal nocturnal haemoglobinuria
Route(s) of administration
Intravenous use
Contact for public enquiries
Alexion Europe SAS
France
Tel. +33 1536 43800
Fax +33 1536 43820
E-mail: pip.enquiries.eu@alxn.com
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating